Manufacturing Industry
Study begins of cobalt-chromium drug eluting stent.(Brief article)
Advanced Materials & Processes, April, 2007
Biotronik has announced the first patient enrollment in the pimecrolimus drug eluting coronary stent first-in-man (FIM) study, ProLimus I. The Biotronik ProGenic stent is made of the highly deliverable Pro-Kinetic cobalt chromium stent system. The Probio silicon carbide passive stent coating is a protective layer that reduces metal ion ...
- Most Popular Articles in Business
- Research and Markets : Tesco Plc - SWOT Framework Analysis
- Do Us a Flavor - Ben & Jerry's Issues a Call for Euphoric New Flavors
- eBay made easy: ready to start an eBay business? These 5 simple steps will ...
- Katrina's lawsuit surge: a legal battle to force insurers to pay for flood ...
- Wal-Mart's newest distribution center opened last month near the southwest ...
- More »